Über Reaktionen Oxygenierter Kobalt (II)-Komplexe. X. 1,4,7,10-Tetraazadecan-kobalt (II) und 4, 7-dimethyl-1,4,7,10-tetraazadecan-kobalt (II) als sauerstoffträger

Reactions of oxygenated cobalt (II) complexes. X. 1,4,7,10-tetraazadecanecobalt (II) and 4,7-dimethyl-1,4,7,10-tetraazadecanecobalt (II) as dioxygen carriers

1 IX: siehe [1].

Oxygenation of cobalt (II) chelates with fourdentate amines such as 1,4,7,10-tetraazadecane (= tad) in aqueous solution yields μ-peroxo-μ-hydroxo-dicobalt (III) complexes. Due to facultative ligand disposition of the amine, 8 different diastereoisomers are possible. Introducing methyl groups in positions 4 and 7 of tad destabilizes the isomers with β-configuration. A crystallized perchlorate, obtained by oxygenation of 4, 7-dimethyl-1,4,7,10-tetraazadecanecobalt (II) (= dmtad) in alcaline solution, proved to be of the expected μ-peroxo-μ-hydroxo type. The ligand configuration is and lattice constants a (ΔΔ/ΛΛ). The X-ray structure was solved by Patterson's method and refined to R = 0.093. The crystals are orthorhombic with space group Pna2₁ and lattice constants a = 14.632 (4), b = 17.525 (5), c = 12.888 (5) Å. In its UV./VIS. absorption spectrum and its solution reactivity the binuclear cation is closely related to oxygenation products obtained with the chelate of unsubstituted tad. The kinetic parameters of the decomposition reaction of the μ-peroxo complexes in acidic solution are compared. The binuclear cations with 4, 7-dimethyl-1,4,7,10-tetraazadecane as ligand are generally more reactive. In slightly alcaline solution isomerization of the μ-peroxo-μ-hydroxo complexes has been observed.     

Metal Complexes with Macrocyclic Ligands,VI. The role of substituents on the complexation rate of transition metal ions with several 1,4,7,10-tetraazacyclotridecanes

12,12-Dimethyl-1,4,7,10-tetraazacyclotridecane (I), 11,13-dimethyl-1,4,7,10-tetraazacyclotridecane (II), 11,11,13-trimethyl-1,4,7,10-tetraazacyclotridecane (III) and 1,4,7,10,12,12-hexamethyl-1,4,7,10-tetraazacyclotridecane (IV) have been synthesized and their properties are described. While the Ni²⁺ and Cu²⁺ complexes of I–III have square planar geometries, those of IV are pentacoordinate according to their absorption spectra. Similarly, while the Co²⁺ complex of I is octahedral and readily oxygenated, the analogous complex with IV is pentacoordinate and not sensitive to oxygen. The rate of complexation of these ligands with Cu²⁺ and Ni²⁺ decreases in the order I > II > III ? IV, indicating that the number as well as the position of the methyl groups are important. Finally for Cu²⁺ the formation of the thermodynamic stable end product is slown down by methyl substitution in α-position to the coordinating nitrogen atoms (ligand II and III) so that an intermediate can be observed, whereas with I Cu²⁺ directly forms the end product.     

Influence of the Coordination of Donor Solvent Molecules to 1,4,7,10-Tetramethyl-1,4,7,10- tetraazacyclododecanenickel(II) and Analogous Nickel(II) Complexes on Their Steric Factors

Coordination equilibrium constants (K _NiS) of some donor solvent molecules to 1,4,7,10-tetramethyl-1,4,7,10-tetraazacyclododecanenickel(II) ([Ni(Me₄[12]aneN₄)]²⁺) were determined in nitrobenzene (a noncoordinating bulk solvent). The first (K _NiS1) and second stepwise coordination equilibrium constants (K _NiS2) for 1,4,7,10-tetraazacyclododecanenickel(II) ([Ni([12]aneN₄)]²⁺), 1,4,8,11-tetraazac yclotetradecane- nickel(II) ([Ni([14] aneN₄)]²⁺), 1,4,8,11-tetrathiacyclotetra-decanenickel(II) ([Ni([14]aneS₄)]²⁺) were also reinvestigated. The K _NiS values for [Ni(Me₄[12]aneN₄)]²⁺ were compared to those of [Ni([12]aneN₄)]²⁺, (1R,4S, 8R,11S)-1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecanenickel(II) (R,S,R,S-[Ni(Me₄[14]aneN₄)]²⁺), R,R,S,S-[Ni(Me₄[14]aneN₄)]²⁺, [Ni([14]aneN₄)]²⁺, and [Ni([14]aneS₄)]²⁺. Coordination of pyridine (Py), N,N,N′,N′-tetramethylurea (TMU), and N,N-dimethylacetamide (DMA) to [Ni(Me₄[12]aneN₄)]²⁺ was observed, although these donor solvent molecules did not coordinate to R,S,R,S-[Ni(Me₄[14]aneN₄)]²⁺. The K _NiS values for Py, TMU, and DMA are 7.9, 2.8, and 9.0 dm³⋅mol⁻¹, respectively. Some hydrogen-bonding waters were coordinated to R,S,R,S-[Ni(Me₄[14]aneN₄)]²⁺, but such waters did not coordinate to [Ni(Me₄[12] aneN₄)]²⁺. Also, the K _NiS2 values were larger than the corresponding K _NiS1 values for [Ni([14]aneS₄)]²⁺. Furthermore, the K _NiS1 values for [Ni([12]aneN₄)]²⁺ were the largest among these nickel(II) complex cations. The K _NiS, K _NiS1, and K _NiS2 values are discussed in terms of properties of the donor solvents and steric strains of these nickel(II) complex cations.     

SYNTHESIS OF NEW CRYPTANDS STARTING FROM TRANS (DIPROTECTED AND DISUBSTITUTED) 1,4,7,10-TETRAAZACYCLODODECANE

ABSTRACT

New cryptands are synthesised by aminolysis between 1,7-di(ethylacetate)-4,10-di(tosyl)-1,4,7,10-tetraazacyclododecane and various diamines.     

1,4,7,10-Tetraoxacyclododecane(12-Crown-4) as Neutral Carrier for Lithium Ion in Lithium Ion Selective Electrode

Abstract

1,4,7,10-Tetraoxacyclododecane (12-crown-4) (I) and its lithium complex (II) are used as neutral carriers for lithium ion in polyvinylchloride membrane ion selective electrodes. The lithium response varies with concentration, being near Mernstian at low (10^?5-10^?4 M) concentrations and sub-Nernstian (24-28 aV) at higher concentrations (10^?3 M). The selectivity coefficients K_Li ^Pot _M for II are: Na⁺ (0.12), K⁺ (0.66), Cs⁺ (0.15), Mg²⁺ (1.6 × 10^?4), Ca²⁺ (3.1 × 10^?4), Ba²⁺ (9.5 × 10^?7), NH⁺ ₄ (9.0 × 10^?2), H⁺ (2.2).     

Lanthanoidkomplexe von 1‐(2‐Propenyl)‐ und 1‐(3‐Butenyl)‐1,4,7,10‐tetraazacyclododecan‐4,7,10‐triessigsäure

η³‐1,4,7,10‐tetraazacyclododecane molybdenum tricarbonyl reacts with allyl bromide and 3‐butenyl bromide in dimethylformamide in the presence of K₂CO₃ yielding 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane ( 1a ) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane ( 1b ), which on their part react with bromoacetic acid tert‐butyl ester in CH₃CN to give 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid tert‐butyl ester ( 2a ) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid tert‐butyl ester ( 2b ), respectively. Compounds 2a and 2b are converted into the corresponding acids 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid ( 4a ) (MPC) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid ( 4b ) (MBC) via the trifluoroacetates 3a and 3b . Sm(NO₃)₃(H₂O)₆, LuCl₃(THF)₃, and TmCl₃(H₂O)₆ react with 4a and 4b forming the lanthanide complexes Sm(MPC) ( 5 ), Lu(MPC) ( 6 ), Tm(MPC) ( 7a ) and Tm(MBC) ( 7b ). The IR as well as the ¹H and ¹³C NMR spectra of the new compounds are reported and discussed.     

Improved Synthesis of 10-(2-Alkylamino-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid Derivatives Bearing Acid-Sensitive Linkers

Alkylation of the hydrobromide salts of 1,4,7-tris(methoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane and 1,4,7-tris(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane with appropriate α-bromoacetamides, followed by hydrolysis, provides convenient access to 10-(2-alkylamino-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derivatives that contain acid-sensitive functional groups. The utility of the method is demonstrated by improved syntheses of two known 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoamides bearing acid-sensitive ω-tritylthio alkyl chains in much greater yields based on cyclen as the starting material.

[Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications® for the following free supplemental resource(s): Full experimental and spectral details.]     

Synthesis and acid-base and complex-forming properties of 1,4,7,10-tetrakis(dihydroxyphosphorylmethyl)-1,4,7,10-tetraazacyclododecane

Conclusions A new complexone, 1,4,7,10-tetrakis(dihydroxyphosphorylmethyl)-1,4,7,10-tetraazacyclododecane, has been synthesized and its acid-base and complex-forming properties have been studied. It shows a very high complexing capability and marked selectivity for cations of large ionic radius (Cd²⁺, Hg²⁺, Pb²⁺, La³⁺).Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 4, pp. 844–849, April, 1984.     

Molecular Recognition of a Peptide by the Nickel(II) Complex of 1,4,7,10‐Tetraazacyclododecane‐2,9‐dione

The nickel(II) complex of the macrocycle 1,4,7,10‐tetraazacyclododecane‐2,9‐dione (dota) was found to be efficient in the recognition of the dipeptide, glycyl‐glycine (Gly‐Gly) in aqueous solution. This (dota)Ni^II complex serves as a targeting molecule to form a stable ternary complex with the dipeptide at pH 8.3 in aqueous solution. The recognition constant (log K=19.20) and the recognition mechanism were investigated based on the potentiometric method. The single‐crystal of a six‐coordinated (dota)₂Ni^II complex is also reported.     

Synthesis,Structure and Solution Properties of Tetra-Azacycles with Pendant Methylene(Phenylphospinic) Groups

Abstract

a large number of macrocycles is derived from 12 or 14-membered tetraazamacrocycles i.c. “cyclen” and “cyclen” respectively. Here we report synthesis, structure and soluction properties of two polyazamacrocycle ligards 1,4,7,10-tetraazacyclotera decane 1,4,8,11-tetrayl-tetra-methylene tetrakia(phenylphoshinic acid) II.     

Acetate and acetamide complexes of [Ni(Me4[12]aneN4)]PF6: a tale of two ligands

Although there are many examples of acetate complexes, acetamide complexes are virtually unknown. A side‐by‐side comparison in (acetato‐κ²O,O′)(1,4,7,10‐tetramethyl‐1,4,7,10‐tetraazacyclododecane‐κ⁴N)nickel(II) hexafluoridophosphate, [Ni(C₂H₃O₂)(C₁₂H₂₈N₄)]PF₆, (1), and (acetamidato‐κ²O,O′)(1,4,7,10‐tetramethyl‐1,4,7,10‐tetraazacyclododecane‐κ⁴N)nickel(II) hexafluoridophosphate, [Ni(C₂H₄NO)(C₁₂H₂₈N₄)]PF₆, (2), shows the steric equivalence between these two ligands, suggesting that acetamide could be considered as a viable acetate replacement for electronic tuning.     

2-(对羟基苯氧基)乙基取代的Cyclen的合成和结构研究

在酸性条件下(pH＝2～3), 1,4,7,10-四氮杂环十二烷(Cyclen)和氯甲酸苄酯反应, 得到高选择性1,7-二保护Cyclen衍生物1,7-二(苄氧基羰基)-1,4,7,10-四氮杂环十二烷(4), 然后在二异丙基乙胺作用下和化合物1-苄氧基-4-(2-溴乙氧基)苯(2)一锅法有效合成了中间体1,7-二(2-对苄氧基苯氧基)乙基-4,10-二(苄氧基羰基)-1,4,7,10-四氮杂环十二烷(5)和4-(2-对苄氧基苯氧基)乙基-1,7-二(苄氧基羰基)-1,4,7,10-四氮杂环十二烷(6), 在乙醇溶液中经Pd/C催化氢解得到两种新型的用取代苯酚基修饰的Cyclen衍生物1,7-二(2-对羟基苯氧基)乙基-1,4,7,10-四氮杂环十二烷(7)和1-(2-对羟基苯氧基)乙基-1,4,7,10-四氮杂环十二烷(8), 其结构经¹H NMR, IR和MS确证. 用单晶X射线衍射法测定了化合物7的晶体结构, 晶体属单斜晶系, C2/c空间群, 晶胞参数a＝2.4145(6) nm, b＝1.6012(4) nm, c＝1.6632(4) nm, α＝γ＝90°, β＝120.360(3)°, V＝5.5486(6) nm³, Z＝8, D_c＝1.146 g/cm³, F(000)＝2056, μ＝0.082 mm^－1, R＝0.0853, wR＝0.2331 [I＞2σ(I)].     

Functionalized di- and tetrathia-crowns and their use to quantitatively separate and recover gold(III), palladium(II), silver(I) and mercury(II) Ions

Two new dithia-crowns containing a hydroxy group and 1,4,7,10-tetrathia-18-crown-6 containing an allyl-oxymethyl substituent were prepared in good yields. Two of these crowns were covalently attached to silica gel. The silica gel-bound thia-crowns were used to separate gold( III ), palladium( II ), silver( I ) and mercury( II ) ions from an aqueous 0.1 M nitric acid solution which also contained 1.0 M ferric chloride.     

New Cyclopendant Organophosphorus Ligands

Abstract

New cyclopendant orgsnophosphorus neutral ligands were synthesized from cyclic polyamines. N,N′,N″-Tris-(diphenylphosphorylmethyl) 1,4,7-triazacyclononane(I) was obtained by the reaction of triazacyclononane with diphenylphosphine oxide and formaldehyde. Interaction of 1,4,7,10-tetraazacyclododecane with diphenylvinyl-phosphine oxide N,N′,N″,N?-tetra(β-diphenylphosphorylethyl)-1,4,7,10-tetraazacyclododecane(II) was obtained.     

Complexation Properties of N,N′,N″,N′′′‐[1,4,7,10‐Tetraazacyclododecane‐1,4,7,10‐tetrayltetrakis(1‐oxoethane‐2,1‐diyl)]tetrakis[glycine] (H4dotagl). Equilibrium,Kinetic, and Relaxation Behavior of the Lanthanide(III) Complexes

Eu³⁺, Dy³⁺, and Yb³⁺ complexes of the dota‐derived tetramide N,N′,N″,N′′′‐[1,4,7,10‐tetraazacyclododecane‐1,4,7,10‐tetrayltetrakis(1‐oxoethane‐2,1‐diyl)]tetrakis[glycine] (H₄dotagl) are potential CEST contrast agents in MRI. In the [Ln(dotagl)] complexes, the Ln³⁺ ion is in the cage formed by the four ring N‐atoms and the amide O‐atom donor atoms, and a H₂O molecule occupies the ninth coordination site. The stability constants of the [Ln(dotagl)] complexes are ca. 10 orders of magnitude lower than those of the [Ln(dota)] analogues (H₄dota=1,4,7,10‐tetraazacyclododecane‐1,4,7,10‐tetraacetic acid). The free carboxylate groups in [Ln(dotagl)] are protonated in the pH range 1–5, resulting in mono‐, di‐, tri‐, and tetraprotonated species. Complexes with divalent metals (Mg²⁺, Ca²⁺, and Cu²⁺) are also of relatively low stability. At pH>8, Cu²⁺ forms a hydroxo complex; however, the amide H‐atom(s) does not dissociate due to the absence of anchor N‐atom(s), which is the result of the rigid structure of the ring. The relaxivities of [Gd(dotagl)] decrease from 10 to 25°, then increase between 30–50°. This unusual trend is interpreted with the low H₂O‐exchange rate. The [Ln(dotagl)] complexes form slowly, via the equilibrium formation of a monoprotonated intermediate, which deprotonates and rearranges to the product in a slow, OH^?‐catalyzed reaction. The formation rates are lower than those for the corresponding Ln(dota) complexes. The dissociation rate of [Eu(dotagl)] is directly proportional to [H⁺] (0.1–1.0M HClO₄); the proton‐assisted dissociation rate is lower for [Eu(H₄dotagl)] (k₁=8.1?10^?6 M ^?1 s^?1) than for [Eu(dota)] (k₁=1.4?10^?5 M ^?1 s^?1).     

Synthesis,structure and antitumor activities of a new macrocyclic ligand with four neutral pendent groups: 1,4,7,10-tetrakisbenzyl-1,4,7,10-tetraazacyclododecane (L) and its Co,Ni and Cu complexes

A new macrocyclic ligand, 1,4,7,10-tetrakisbenzyl-1,4,7,10-tetraazacyclododecane (L) and its three new divalent metal complexes of general formula: M(NO₃)₂(L)nH2O [M = Co(1), Ni(2), n = 0; M = Cu(3), n = 1.5] have been synthesized and characterized by elemental analysis, i.r., EI mass spectra and molecular conductance. Complex (2) has been characterized by X-ray diffraction. In complex (2), the central Ni^II atom coordinatively bonds to four nitrogen atoms of the macrocyclic ligand and two oxygen atoms of nitrate anion, to form a distorted octahedron. X-ray diffraction indicated that the bonds Ni–N(1), Ni–N(2), Ni–N(3) and Ni–N(4) are of almost equal length, i.e. 2.11(1), 2.12(1), 2.10(1) and 2.17(1)Å, respectively. Bond lengths of Ni–O(1) and Ni– O(2) are 2.11(1) and 2.10(1)Å. Preliminary pharmacological tests show that these complexes have high antitumor activity towards HL-60 tumor cell lines.     

A stable derivative of cyclooctatrienyne: Synthesis and crystal structures of 1,4,7,10-tetramethyl-5,6-didehydrodibenzo[a,e]cyclooctene and 1,4,7,10-tetramethyldibenzo[a,e]cyclooctene

A stable derivative of cyclooctatrienyne (1), namely 1,4,7,10-tetramethyl-5,6-didehydrodibenzo-[a,e]cyclooctene (3), has been synthesized and fully characterized. X-Ray crystallographic analyses indicate that 3 adopts a “butterfly” conformation intermediate between those of virtually planar 5,6-didehydrodibenzo-[a,e]cyclooctene (2) and tub-shaped 1,4,7,10-tetramethyldibenzo[a,e]cyclooctene(16). The methyl substituents effectively shield the otherwise rather exposed strained triple bond of 3 and kinetically stabilize it against dimerization and/or air oxidation.     

Optical Determination of Glucose with Glucose Oxidase Immobilized in PVC together with Fluorescent Oxazol‐5‐One Derivatives

Abstract

Fully reversible biosensors for glucose monitoring based on solid polyvinylchloride (PVC) films where the enzyme glucose oxidase (GOx) was incorporated together with 2‐phenyl‐4‐[4‐(1,4,7,10‐tetraoxa‐13‐azacyclopentadecyl)benzylidene]‐5‐oxazolone (CPO‐1), 2‐(3,5‐dinitrophenyl)‐4‐[4‐(1,4,7,10‐tetraoxa‐13‐azacyclopentadecyl)benzylidene]‐5‐oxazolone (CPO‐2), 2‐(4‐nitrophenyl)‐4‐[4‐(1,4,7,10‐tetraoxa‐13‐azacyclopentadecyl)benzylidene]‐5‐oxazolone (CPO‐3) and 2‐(4‐tolyl)‐4‐[4‐(1,4,7,10‐tetraoxa‐13‐azacyclopentadecyl)benzylidene]‐5‐oxazolone (CPO‐4) derivatives have been developed. The limit of detection (LOD) values for glucose were found to be 1.47×10^?5 M, 2.01×10^?5 M, 0.89×10^?5 M, and 0.12×10^?5 M for CPO‐1, CPO‐2, CPO‐3, and CPO‐4, respectively (n=7). Sensor films were found to have excellent photostability.     

On the Synthesis of 1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane

1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane is widely used as an intermediate in the preparation of medically important DO3A and DOTA metal chelators. Despite its commercial availability and importance, the literature describing the preparation and properties of the free base is limited and sometimes unclear. We present herein an efficient synthesis of the hydrobromide salt of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, characterize this compound spectroscopically and by X-ray crystallographic analysis, describe its simple conversion to the corresponding free base, characterize this compound spectroscopically and by X-ray crystallographic analysis, and make observations on the reactivity of this interesting and useful compound.     

Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds

A convenient synthesis of novel bifunctional poly(amino carboxylate) chelating agents allowing chemoselective attachment to highly functionalized biomolecules is described. Based on the well known chelator 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA), we synthesized novel bifunctional chelating agents bearing additional functional groups by alkylating 1,4,7,10-tetraazacyclododecane (cyclen) with one equivalent of para-functionalized alkyl 2-bromophenyl-acetate and three equivalents of tert-butyl 2-bromoacetate. The resulting compounds, which contain an additional carbonyl or alkyne functionality, allow site specific labeling of appropriately functionalized unprotected biomolecules in a rapid manner via click reactions. This was demonstrated by the attachment of our new DOTA derivatives to the somatostatin analogue Tyr3-octreotate by chemoselective oxime ligation and CuI-catalyzed azide-alkyne cycloaddition. Initial biodistribution studies in mice with the radiometalated compound demonstrated the applicability of the described DOTA conjugation.